The stealth effect plays a central role on capacitating nanomaterials for drug delivery
applications through improving the pharmacokinetics such as blood circulation …

Extracellular vesicles (EVs) are membrane-derived particles surrounded by a (phospho)
lipid bilayer that are released by cells in the human body. In addition to direct cell-to-cell …

Extracellular vesicles (EVs) are nanosized vesicles released by normal and diseased cells
as a novel form of intercellular communication and can serve as an effective therapeutic …

The results obtained in this study establish that liposome formulations incorporating a
synthetic polyethylene glycol-derivatized phospholipid have a pronounced effect on …

The discovery of liposome or lipid vesicle emerged from self forming enclosed lipid bi-layer
upon hydration; liposome drug delivery systems have played a significant role in formulation …

Alzheimer's disease (AD) will affect around 115 million people worldwide by the year 2050.
It is associated with the accumulation of misfolded and aggregated proteins (β-amyloid and …

Liposomes, phospholipid vesicles with a bilayered membrane structure, have been widely
used as pharmaceutical carriers for drugs and genes, in particular for treatment of cancer. To …

Liposome drug delivery systems are being developed for a variety of drugs. Scale-up
process to larger size batches is often a monumental task for the process development …

Many recent reports have demonstrated that rapid uptake of liposomes in vivo by cells of the
mononuclear phagocytic systcm (MPS), which has restricted their therapeutic utility, can be …

Extracellular vesicles (EVs) comprise a heterogeneous group of small membrane vesicles,
including exosomes, which play a critical role in intracellular communication and regulation …